PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 232 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134 | -3.6% | 16,000 | -5.9% | 0.01% | 0.0% |
| Q4 2022 | $139 | -99.9% | 17,000 | -61.8% | 0.01% | 0.0% |
| Q2 2022 | $197,000 | -27.8% | 44,549 | +48.5% | 0.01% | -14.3% |
| Q1 2022 | $273,000 | -98.2% | 30,000 | -98.0% | 0.01% | -98.9% |
| Q3 2020 | $15,001,000 | -19.6% | 1,519,832 | -71.9% | 1.27% | -25.7% |
| Q2 2020 | $18,660,000 | +12.0% | 5,408,764 | -0.6% | 1.72% | +42.4% |
| Q1 2020 | $16,657,000 | -31.3% | 5,443,564 | +15.4% | 1.20% | -28.8% |
| Q4 2019 | $24,255,000 | +2.4% | 4,718,964 | +2.8% | 1.69% | +14.9% |
| Q3 2019 | $23,685,000 | -49.5% | 4,590,150 | -40.8% | 1.47% | +35.5% |
| Q2 2019 | $46,928,000 | -10.4% | 7,756,672 | +7.0% | 1.09% | -24.0% |
| Q1 2019 | $52,398,000 | +418.9% | 7,247,354 | +431.1% | 1.43% | +90.2% |
| Q4 2018 | $10,098,000 | – | 1,364,531 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |